Browsing by Author "Yazici, H"
Now showing 1 - 4 of 4
Results Per Page
Sort Options
Item Preparation and Characterization of Hydroxyethyl Cellulose/Nanolignin Composite FilmsZor, M; Yazici, H; Sen, F; Eroglu, E; Candan, Z; Rodrigue, D; Wang, XDHydroxyethyl cellulose/nanolignin composite films were prepared and characterized. The composite films were produced via casting of synthesized nanolignin added to hydroxyethyl cellulose at different concentrations (2.5%, 5%, 10%, and 20% by mass). A control film without nanolignin was also prepared for comparison. The thermal properties of the composite films were examined by thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC), while the mechanical properties were determined by tensile testing and the surface properties were determined by water contact angle measurements. In addition, the morphologies of the samples were examined by scanning electron microscopy (SEM). It was observed that with the addition of nano lignin, the glass transition temperature of the composite films increased from 109 degrees C to 262 degrees C; the elongation at break increased from 19% to 51%; and the contact angles increased from 53 degrees C to 73 degrees C. The results showed that the presence of nanolignin produced materials being more flexible and more hydrophobic with higher glass transition temperatures.Item Four cases of Chanarin-Dorfman syndrome presenting with different types of erythrokeratodermaÇetinarslan, T; Yazici, H; Erdogan, KM; Uçar, SK; Dalgiç, G; Kaya, G; Er, E; Bilaç, C; Temiz, P; Ermertcan, AT; Fölster-Holst, RChanarin-Dorfman syndrome (CDS) is a multisystem autosomal recessive disorder due to variants of the ABHD5 gene, characterized by lipid vacuoles in the liver and leukocytes, and possible involvement of eyes, ears, skeletal muscle, and central nervous system. CDS may present with skin changes, most commonly congenital non- bullous ichthyosiform erythroderma, however erythrokeratoderma-like findings have been rarely reported in CDS patients. Herein, we report clinical, histopathological and genetic findings of four patients with CDS presenting with different clinical forms of erythrokeratoderma (three with progressive symmetric erythrokeratoderma-like features and one with erythrokeratoderma variabilis (EKV)-like features), including one patient with a novel mutation in ABHD5. Although the typical skin finding of CDS syndrome is reported as non-bullous congenital ichthyosiform erythroderma, CDS should also be in the differential diagnosis in patients with EKV-like lesions.Item Coinheritance of novel mutations in NAGLU causing mucopolysaccharidosis type IIIB and in DDHD2 causing spastic paraplegia54 in a Turkish familyBilgic, DG; Celebi, HBG; Gumus, AA; Bilgic, A; Yazici, H; Ceylaner, S; Yilmaz, C; Polat, M; Sahin, MA; Dereli, F; Cam, FSMucopolysaccharidosis type IIIB (MPSIIIB) is one of the lysosomal storage diseases, clinically related to developmental delay in the early phase and loss of skills in the late phases of the disease. The disease is caused by homozygous mutations in the NAGLU gene. Spastic paraplegia54 (SPG54) is a neurodegenerative disorder caused by homozygous mutations in the DDHD2 gene. Clinical features are progressive spasticity and weakness in the lower limbs and corpus callosum agenesis. We report on two siblings in a consanguineous family, presenting both the clinical and molecular diagnoses of MPSIIIB and SPG54 with novel mutations by using whole exome sequencing (WES). This interesting finding shows that we should be aware of the importance of using WES for diagnosing rare diseases in consanguineous families. (C) 2020 Elsevier Ltd. All rights reserved.Item Turkish Guideline for Diagnosis and Treatment of Allergic Rhinitis (ART)Ecevit, MC; Özcan, M; Can, IH; Tatar, EC; Özer, S; Esen, E; Atan, D; Göde, S; Elsurer, C; Eryilmaz, A; Coskun, BU; Yazici, ZM; Dinç, ME; Ozdogan, F; Gunhan, K; Bilal, N; Korkut, AY; Kasapoglu, F; Türk, B; Server, EA; Çelebi, ÖÖ; Simsek, T; Kum, RO; Adali, MK; Eren, E; Aslier, NGY; Bayindir, T; Çetin, AC; Göker, AE; Güvenç, IA; Köseoglu, S; Özler, GS; Sahin, E; Yilmaz, AS; Güne, C; Yildirim, GA; Öca, B; Durmusoglu, M; Kantekin, Y; Özmen, S; Kubat, GO; Sanal, SK; Altuntas, EE; Selçuk, A; Yazici, H; Baklaci, D; Yaylaci, A; Hanci, D; Dogan, S; Fidan, V; Uygur, K; Keles, N; Cingi, C; Topuz, B; Çanakçioglu, S; Önerci, MObject: To prepare a national guideline for Oto-rhinolaryngologist who treat allergic rhinitis patients Methods: The study was conducted by three authors, namely the writing support team. The support team made the study plan, determined the writing instructions, chose the subgroups including the advisory committee, the advisors for authors and the authors. A workshop was organized at the very beginning to explain the details of the study to the team. Advisors took the chance to meet their coworkers in their subgroups and determined the main headings and subheadings of the guideline, together with the authors. After key words were determined by the authors, literature search was done in various databases. The authors keep in touch with the advisors and the advisors with the advisory committee and the support group at every stage of the study. National and International published articles as well as the abstracts of unpublished studies, imperatively presented in National Congresses, were included in this guideline. Only Guideline and meta-analyses published in last seven years (2013- 2017) and randomized controlled studies published in last two years (2015- 2017) were included. After all work was completed by the subgroups, support team brought all work together and edited the article. Results: A detailed guideline about all aspects of allergic rhinitis was created. Conclusion: The authors believe that this guideline will enable a compact and up-to-date information on allergic rhinitis to healthcare professionals. This guideline is the first in the field of Otolaryngology in Turkey. It should be updated at regular intervals.